XML 37 R23.htm IDEA: XBRL DOCUMENT v3.23.2
Segment Information
 6 Months Ended
Jun. 30, 2023
Segment Reporting [Abstract]  
Segment Information Segment Information
Engineered
Materials		Acetyl
Chain		Other
Activities		EliminationsConsolidated
(In $ millions)
Three Months Ended June 30, 2023
Net sales1,585 1,233 — (23)(1)2,795 
Other (charges) gains, net (Note 18)
(8)— (2)— (10)
Operating profit (loss)158 295 (118)— 335 
Equity in net earnings (loss) of affiliates
18 2 3 — 23 
Depreciation and amortization112 54 6 — 172 
Capital expenditures58 67 27 — 152 (2)
Three Months Ended June 30, 2022
Net sales
948 1,559 — (21)(1)2,486 
Other (charges) gains, net (Note 18)
1 — — — 1 
Operating profit (loss)
166 428 (111)— 483 
Equity in net earnings (loss) of affiliates
53 3 4 — 60 
Depreciation and amortization
45 52 6 — 103 
Capital expenditures
35 87 10 — 132 (2)
______________________________
(1)Includes intersegment sales primarily related to the Acetyl Chain.
(2)Includes an increase in accrued capital expenditures of $7 million and $8 million for the three months ended June 30, 2023 and 2022, respectively.
Engineered
Materials		Acetyl
Chain		Other
Activities		EliminationsConsolidated
(In $ millions)
Six Months Ended June 30, 2023
Net sales3,215 2,483 — (50)(1)5,648 
Other (charges) gains, net (Note 18)
(29)(1)(3)— (33)
Operating profit (loss)270 573 (257)— 586 
Equity in net earnings (loss) of affiliates
29 3 6 — 38 
Depreciation and amortization224 108 12 — 344 
Capital expenditures103 118 39 — 260 (2)
As of June 30, 2023
Goodwill and intangible assets, net
10,646 424 — — 11,070 
Total assets
18,146 5,589 1,914 — 25,649 
Six Months Ended June 30, 2022
Net sales
1,858 

3,211 

— (45)(1)5,024 
Operating profit (loss)
290 931 (207)— 1,014 
Equity in net earnings (loss) of affiliates
102 7 7 — 116 
Depreciation and amortization
91 108 10 — 209 
Capital expenditures
65 157 24 — 246 (2)
As of December 31, 2022
Goodwill and intangible assets, net
10,826 421 — — 11,247 
Total assets
20,611 5,471 190 — 26,272 
______________________________
(1)Includes intersegment sales primarily related to the Acetyl Chain.
(2)Includes a decrease in accrued capital expenditures of $49 million and $15 million for the six months ended June 30, 2023 and 2022, respectively.